SAVANNAH, Ga.October 2, 2007, MIT Holding, Inc. (OTCBB: MITD - News), has signed an agreement with Georgia Southern University to research products to stop the spread of infectious diseases. Dr. Thomas M. Kollars, Jr., the Company's Chief Scientific Advisor and Director of the Biodefense and Infectious Disease Laboratory and Associate Professor of Epidemiology in the Jiann-Ping Hsu College of Public Health, Georgia Southern University, will oversee the project.
This is a significant partnership for MIT Holding, commented William C. Parker, Chief Executive Officer of MIT Holding. Georgia Southern University has extensive experience in public health research and well documented clinical data that will support our program. We look forward to working with Dr. Kollars and his team of experts to develop a product that could potentially save millions of lives through stopping the spread of infectious diseases, including malaria, dengue fever and West Nile virus.
We share the same ambition as MIT to stop the spread of infectious diseases, commented Dr. Kollars. The effects of infectious diseases are widespread, and account for millions of deaths every year. We have worked extensively to understand the epidemiology of these diseases, and are close to finalizing a product that could potentially save millions of lives. MIT has a strong distribution network and years of experience compounding pharmaceuticals. We look forward to working with the team at MIT to conclude the last component of our research, which we believe will create a commercially available product that will help eradicate infectious diseases within geographic areas.
|Contact: Janet Vasquez|